INTEGRATIVE HEALTH TECHNOLOGIES, INC. Integrative Health Technologies, Inc. Stock
Equities
IHTI
US45822A2078
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
Financials (USD)
| Sales 2008 | 0.43 | Sales 2009 | 0.45 | Capitalization | 1.22M |
|---|---|---|---|---|---|
| Net income 2008 | - | Net income 2009 | - | EV / Sales 2008 | 14,379,727 x |
| Net Debt 2008 | 99.02K | Net Debt 2009 | 94.3K | EV / Sales 2009 | 2,939,517 x |
| P/E ratio 2008 |
231
x | P/E ratio 2009 |
31.6
x | Employees | - |
| Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 48.33% |
More Fundamentals
* Assessed data
More press releases
3 years
0.00
0.03
5 years
0.000.05
10 years
0.000.05
| Managers | Title | Age | Since |
|---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Samuel C. Keith
CIO | Chief Investment Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Integrative Health Technologies, Inc. operates as an independent clinical research organization (CRO) providing pilot studies and clinical trials of non-pharmaceutical products and plans for the medical, biotech and nutritional supplement industries. The Company is providing pilot studies and clinical trials of non-pharmaceutical products. The Company is building a longitudinal database of medical biomarkers for analysis of inter-and intra-relationships between A 45 -panel of fasting blood chemistries, dual energy x-ray absorptiometry (DEXA) total body scans of fat, and lean and bone density/bone mineral content for the medical, biotech and nutritional supplement industries.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 40 | |
| +1.51% | 42.75B | |
| +48.37% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- IHTI Stock
